Corcept Therapeutics (CORT) Inventory (2012 - 2026)
Corcept Therapeutics (CORT) posted Inventory of $13.2 million for Q2 2026, up 2.29% sequentially from $12.9 million in Q1 2026, and up 7.4% YoY from $12.3 million in Q2 2025.
Corcept Therapeutics (CORT) Inventory (2012 - 2026) Analysis & Trends
Corcept Therapeutics has reported Inventory for 15 years, with the latest figure at $13.2 million in Q2 2026.
- Quarterly Inventory rose 7.4% year-over-year to $13.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.2 million (up 7.4% YoY) and the FY2025 annual result came in at $12.9 million, up 3.67% from the prior year.
- Inventory advanced to $13.2 million in Q2 2026 per CORT's latest filing, from $12.9 million in the prior quarter.
- Over five years, Inventory peaked at $14.4 million in Q1 2025 and troughed at $5.1 million in Q1 2022.
- A 5-year average of $9.2 million and a median of $7.9 million in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2025 and 2026: Inventory jumped 99.83% in 2025, then fell 10.29% in 2026.
- Over 5 years, Inventory stood at $6.1 million in 2022, then rose by 26.72% to $7.7 million in 2023, then surged by 60.57% to $12.4 million in 2024, then climbed by 3.67% to $12.9 million in 2025, then increased by 2.46% to $13.2 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $13.2 million, $12.9 million, and $12.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 13.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.19 Mn |
| Mar 31, 2026 | 12.89 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Sep 30, 2025 | 12.35 Mn |
| Jun 30, 2025 | 12.28 Mn |
| Mar 31, 2025 | 14.37 Mn |
| Dec 31, 2024 | 12.41 Mn |
| Sep 30, 2024 | 8.05 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 6.10 Mn |
| Sep 30, 2022 | 6.05 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 5.08 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 4.99 Mn |